Accueil・Liste d'Actions・Abbott Laboratories

Abbott Laboratories

Fermé

SecteurSoins de santé

116.11 -0.52

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

115.29

Max

117.31

Chiffres clés
By Trading Economics
Revenu	-149M 928M
Ventes	1.4B 13B
P/E Moyenne du Secteur	35.951 57.371
BPA	1.31
Rendement du dividende	2.23
Marge bénéficiaire	7.369
Employés	122,000
EBITDA	-465M 1.8B

Recommandations
By TipRanks
Recommandations	Achat Fort
Prévisions sur 12 Mois	+5.63% upside

Dividendes
By Acuity
Rendement du dividende Moyenne du Secteur	2.23% 2.23%
Prochains Résultats	14 oct. 2026
Date du Prochain Détachement de Dividende	14 oct. 2026

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	27B 191B
Ouverture précédente	116.63
Clôture précédente	116.11

Sentiment de l'Actualité

By Acuity

26%

74%

80 / 340 Classement par Healthcare

Abbott Laboratories Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

24 août 2026, 23:01 UTC

Abbott Laboratories shares are trading lower in after-market hours. Broader market weakness and geopolitical tensions are contributing to the price movement.

21 août 2026, 23:01 UTC

Abbott Laboratories shares were lower in after-market trading, despite being above the 20-day moving average and near the upper end of their one-month range.

20 août 2026, 23:01 UTC

News

Abbott Laboratories settles litigation for $670 million over preterm infant formulas, trading lower in after-market hours following the news.

19 août 2026, 23:01 UTC

Abbott Laboratories shares are lower in after-market hours following a volatile session, despite trading above their 20-day moving average. No specific news was identified.

18 août 2026, 23:16 UTC

Shares of Abbott Laboratories are higher in after-market trading, remaining above the 20-day moving average and near the upper end of the one-month range.

17 août 2026, 23:41 UTC

Abbott Laboratories shares are trading lower in after-market hours. Broader market volatility is linked to rising crude oil prices and geopolitical tensions.

14 août 2026, 23:02 UTC

Abbott Laboratories shares are trading higher in after-market hours, showing strength above the 20-day moving average despite mixed market sentiment and declining U.S. retail sales.

13 août 2026, 23:01 UTC

Abbott Laboratories shares are lower in after-market trading, with no specific news identified to explain the decline. The stock remains above its 20-day moving average.

12 août 2026, 23:46 UTC

Abbott Laboratories shares are lower in after-market trading, with no specific news identified for the decline. Broader market optimism follows recent inflation data.

11 août 2026, 19:16 UTC

News

Abbott Laboratories announced a partnership with Google Health to enhance glucose management through AI. Shares are trading higher amid positive market sentiment.

10 août 2026, 23:46 UTC

Abbott Laboratories shares are lower in after-market hours, with no specific news identified for the decline. The stock remains above its 20-day moving average.

7 août 2026, 23:06 UTC

Abbott Laboratories shares declined slightly in after-market trading. The stock remains above its 20-day moving average and near the upper end of its one-month range.

6 août 2026, 23:01 UTC

Abbott Laboratories shares are lower in after-market hours, amid broader market weakness and rising initial jobless claims contributing to tightening expectations.

5 août 2026, 23:02 UTC

Abbott Laboratories shares are lower in after-market trading, following a brief peak post-close. Broader market conditions may be influencing sentiment amid weaker U.S. job growth data.

4 août 2026, 20:06 UTC

Abbott Laboratories shares are lower today, tracking broader market declines amid falling crude oil prices and ongoing discussions about potential peace talks.

3 août 2026, 23:06 UTC

Abbott Laboratories shares are near unchanged in after-market trading, positioned 7.52% above the 20-day moving average and near the upper end of the one-month range.

31 juil. 2026, 23:01 UTC

Abbott Laboratories shares are modestly higher in after-market trading. The stock remains elevated, 7.16% above its 20-day moving average.

30 juil. 2026, 23:51 UTC

Abbott Laboratories shares are higher in after-market trading, recovering from earlier losses. The stock trades significantly above its 20-day moving average.

29 juil. 2026, 23:01 UTC

Abbott Laboratories shares are lower in after-market hours, continuing recent volatility amid mixed global market performance and rising geopolitical tensions in the Middle East.

28 juil. 2026, 23:02 UTC

Abbott Laboratories shares are higher in after-market hours, showing notable volatility post-close while remaining above the 20-day moving average. No specific news was identified.

27 juil. 2026, 23:02 UTC

Abbott Laboratories shares are lower in after-market hours, with no specific news identified to explain the movement. Broader market sentiment may be influencing the decline.

24 juil. 2026, 20:02 UTC

News

A court dismissed a shareholder lawsuit regarding Abbott Laboratories' 2022 infant formula recall, boosting market sentiment as shares trade higher with increased volume.

23 juil. 2026, 23:41 UTC

Abbott Laboratories shares are lower in after-market hours amid broader market weakness, particularly in the bond market, with no specific company news identified.

22 juil. 2026, 22:06 UTC

Abbott Laboratories shares are higher in after-market trading, positioned above their 20-day moving average and near the upper end of their one-month trading range.

21 juil. 2026, 19:01 UTC

Abbott Laboratories is lower today, continuing a decline that began Monday. The stock has dropped from an early peak amid no specific news.

20 juil. 2026, 23:06 UTC

Abbott Laboratories shares are lower in after-market hours, with no specific news identified. Broader market volatility stems from rising Treasury yields and geopolitical tensions.

Comparaison

Variation de prix

Abbott Laboratories prévision

Objectif de Prix

By TipRanks

5.63% hausse

Prévisions sur 12 Mois

Moyen 123.21 USD 5.63%

Haut 135 USD

Bas 112 USD

Basé sur 16 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

16 ratings

Achat

Maintien

Vente

Basé sur 16 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Sentiment

By Acuity

80 / 340Classement par Soins de santé

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.